A new evidence-based clinical practice guideline addresses adverse events, surgical risks, and patient education
Practitioners may use risk assessment tools to help predict a variety of perioperative outcomes and adverse events in patients who are candidates for THA.
Obese patients with hip OA may have less positive overall outcomes than non-obese patients but moderate evidence supports similar satisfaction and improvement in pain/function after THA.
Increased age is linked with lower functional and quality-of-life outcomes in patients with symptomatic hip OA undergoing THA.
Mood and anxiety disorders are associated with poorer overall outcomes in patients who undergo THA; smoking places patients at risk for perioperative complications.
NSAIDs are recommended to improve short-term pain and/or function in patients with symptomatic hip OA but glucosamine did not perform better than placebo for providing relief.
Strong evidence supports intra-articular steroids to reduce pain/improve function in the short term for patients with hip OA but not hyaluronic acid injections which did not perform better than placebo.
A new evidence-based clinical practice guideline for managing osteoarthritis (OA) of the hip, with a focus on the risks of total hip arthroplasty (THA), has been issued by the American Academy of Orthopaedic Surgeons.Scroll through the slides above for highlights.